<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=2258623" created="11/04/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>2258623</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Differences in <term id="T1" lex="transcriptional_enhancer" sem="DNA_domain_or_region">transcriptional enhancers</term> of <term id="T2" lex="HIV-1" sem="Virus">HIV-1</term> and <term id="T3" lex="HIV-2" sem="Virus">HIV-2</term>.</sentence>
<sentence id="S2">Response to <term id="T4" lex="T_cell_activation_signals" sem="Other"><term id="T5" lex="T_cell" sem="Cell_natural">T cell</term> activation signals</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Regulation"/>
<theme idref="T1" idref1="T2"/>
<cause idref="T4"/>
<clue><clueType>Response</clueType> <linkCause>to</linkCause> T cell activation signals.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Regulation"/>
<theme idref="T1" idref1="T3"/>
<cause idref="T4"/>
<clue><clueType>Response</clueType> <linkCause>to</linkCause> T cell activation signals.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S3"><term id="T6" lex="T_cell_activation" sem="Other"><term id="T7" lex="T_cell" sem="Cell_natural">T cell</term> activation</term> results in high levels of <term id="T8" lex="HIV_replication" sem="Other"><term id="T9" lex="HIV" sem="Virus">HIV</term> replication</term> and is thought to be one mechanism leading to the conversion from <cons id="T10" lex="(TO latent_viral_infection active_viral_infection)" sem="(TO Other Other)"><frag id="F1"><term id="A1" sem="Other">latent</term></frag> to <frag id="F2"><term id="A2" sem="Other">active</term></frag> <frag id="F3"><term id="A3" sem="Other">viral infection</term></frag></cons>.</sentence>
<event KT="Other" id="E3">
<type class="Physiological_process"/>
<theme idref="T7"/>
<clue>T cell <clueType>activation</clueType> results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection.</clue>
</event>
<event KT="Other" id="E4">
<type class="Viral_life_cycle"/>
<theme idref="T9"/>
<clue>T cell activation results in high levels of HIV <clueType>replication</clueType> and is thought to be one mechanism leading to the conversion from latent to active viral infection.</clue>
</event>
<event KT="Other" Manner="High" id="E29">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<clue>T cell activation results in <clueType><clueManner>high levels</clueManner></clueType> <linkTheme>of</linkTheme> HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="E3"/>
<clue>T cell activation <clueType>results</clueType> <linkTheme>in</linkTheme> high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection.</clue>
</event>
<event CL="L2" KT="Analysis" Source="Other" id="E6" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="A1" idref1="A3"/>
<theme idref="A2" idref1="A3"/>
<cause idref="E3"/>
<clue>T cell activation results in high levels of HIV replication and <clueSource>is <clueKT><clueCL>thought</clueCL></clueKT> to be</clueSource> one mechanism <clueType>leading to the conversion</clueType> <linkTheme>from</linkTheme> latent <linkTheme>to</linkTheme> active viral infection.</clue>
<comment>CAUTION: from A1,A3 to A2,A3</comment></event>
<sentence id="S4">In <term id="T11" lex="HIV-1" sem="Virus">HIV-1</term>, the <term id="A4" sem="DNA_domain_or_region">sequences</term> that respond to these <term id="T12" lex="signaling_event" sem="Other">signaling events</term> are found in the <term id="T13" lex="long_terminal_repeat" sem="DNA_domain_or_region">long terminal repeat</term> (<term id="T14" lex="LTR" sem="DNA_domain_or_region">LTR</term>) and comprise the <term id="T15" lex="transcriptional_enhancer" sem="DNA_domain_or_region">transcriptional enhancer</term>, which contains two <term id="T16" lex="conserved_binding_sites" sem="DNA_domain_or_region">conserved binding sites</term> for the <term id="T17" lex="nuclear_factor_kappa_B" sem="Protein_molecule">nuclear factor kappa B</term> (<term id="T18" lex="NF_kappa_B" sem="Protein_molecule">NF kappa B</term>).</sentence>
<event KT="Other" id="E7">
<type class="Regulation"/>
<theme idref="A4"/>
<cause idref="T12"/>
<clue><clueLoc>In HIV-1</clueLoc>, the sequences that <clueType>respond</clueType> <linkCause>to</linkCause> these signaling events are found in the long terminal repeat (LTR) and comprise the transcriptional enhancer, which contains two conserved binding sites for the nuclear factor kappa B (NF kappa B).</clue>
</event>
<sentence id="S5">The corresponding region in the <term id="T19" lex="second_AIDS_retrovirus" sem="Virus">second AIDS retrovirus</term>, <term id="T20" lex="HIV-2" sem="Virus">HIV-2</term>, contains a conserved and a divergent <term id="T21" lex="NF_kappa_B_binding_site" sem="DNA_domain_or_region"><term id="T22" lex="NF_kappa_B" sem="Protein_molecule">NF kappa B</term> binding site</term>.</sentence>
<sentence id="S6">We demonstrate that the <term id="T23" lex="HIV-1_LTR" sem="DNA_domain_or_region"><term id="T24" lex="HIV-1" sem="Virus">HIV-1</term> LTR</term> responds better than the <term id="T25" lex="HIV-2_LTR" sem="DNA_domain_or_region"><term id="T26" lex="HIV-2" sem="Virus">HIV-2</term> LTR</term> to <term id="A5" sem="Other">T cell activation signals</term>.</sentence>
<event KT="Analysis" id="E8">
<type class="Regulation"/>
<theme idref="T23"/>
<cause idref="A5"/>
<clue>We <clueKT>demonstrate</clueKT> that the HIV-1 LTR <clueType>responds</clueType> better than the HIV-2 LTR <linkCause>to</linkCause> T cell activation signals.</clue>
</event>
<event KT="Analysis" id="E9">
<type class="Regulation"/>
<theme idref="T25"/>
<cause idref="A5"/>
<clue>We <clueKT>demonstrate</clueKT> that the HIV-1 LTR <clueType>responds</clueType> better than the HIV-2 LTR <linkCause>to</linkCause> T cell activation signals.</clue>
<comment>CAUTION: SEE</comment></event>
<sentence id="S7">These qualitative differences in the response to <term id="T27" lex="T_cell_activation" sem="Other"><term id="T28" lex="T_cell" sem="Cell_natural">T cell</term> activation</term> are reproduced not only when <cons id="T29" lex="(OR HIV-1_enhancer HIV-2_enhancer)" sem="(OR DNA_domain_or_region DNA_domain_or_region)"><frag id="F4"><term id="A6" sem="DNA_domain_or_region">HIV-1</term></frag> or <frag id="F5"><term id="A7" sem="DNA_domain_or_region">HIV-2</term></frag> <frag id="F6"><term id="A8" sem="DNA_domain_or_region">enhancers</term></frag></cons> are placed upstream of a <term id="T30" lex="heterologous_promoter" sem="DNA_domain_or_region">heterologous promoter</term> but also when these <term id="T31" lex="enhancer" sem="DNA_family_or_group">enhancers</term> are switched between their respective <term id="T32" lex="LTR" sem="DNA_domain_or_region">LTR</term>.</sentence>
<event id="E10">
<type class="Physiological_process"/>
<theme idref="T28"/>
<clue>These qualitative differences in the response to T cell <clueType>activation</clueType> are reproduced not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also when these enhancers are switched between their respective LTR.</clue>
</event>
<event id="E11">
<type class="Regulation"/>
<cause idref="E10"/>
<clue>These qualitative differences in the <clueType>response</clueType> <linkCause>to</linkCause> T cell activation are reproduced not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also when these enhancers are switched between their respective LTR.</clue>
<comment>NO THEME</comment></event>
<event id="E21">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="E27"/>
<clue><corefTheme>These qualitative differences</corefTheme> in the response to T cell activation are <clueType>reproduced</clueType> not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also <linkCause>when</linkCause> these enhancers are switched between their respective LTR.</clue>
</event>
<event id="E22">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="E28"/>
<clue><corefTheme>These qualitative differences</corefTheme> in the response to T cell activation are <clueType>reproduced</clueType> not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also <linkCause>when</linkCause> these enhancers are switched between their respective LTR.</clue>
</event>
<event KT="Method" id="E27">
<type class="Mutagenesis"/>
<theme idref="A6" idref1="A8"/>
<theme idref="A6" idref1="T32"/>
<clue>These qualitative differences in the response to T cell activation are reproduced not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also when <corefTheme>these enhancers</corefTheme> are <clueType>switched</clueType> <linkTheme>between</linkTheme> their respective LTR.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Method" id="E28">
<type class="Mutagenesis"/>
<theme idref="A7" idref1="A8"/>
<theme idref="A7" idref1="T32"/>
<clue>These qualitative differences in the response to T cell activation are reproduced not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also when <corefTheme>these enhancers</corefTheme> are <clueType>switched</clueType> <linkTheme>between</linkTheme> their respective LTR.</clue>
<comment>ARTIFICIAL</comment></event>
<sentence id="S8">In electrophoretic mobility shift assays, <term id="T33" lex="NF_kappa_B" sem="Protein_molecule">NF kappa B</term> binds to both <term id="A9" sem="DNA_domain_or_region">conserved sites</term> in the <term id="T34" lex="HIV-1_transcriptional_enhancer" sem="DNA_domain_or_region"><term id="T35" lex="HIV-1" sem="Virus">HIV-1</term> transcriptional enhancer</term> and only to the single <term id="A12" sem="DNA_domain_or_region">conserved site</term> in the <term id="T36" lex="HIV-2_transcriptional_enhancer" sem="DNA_domain_or_region"><term id="T37" lex="HIV-2" sem="Virus">HIV-2</term> transcriptional enhancer</term>.</sentence>
<event id="E14">
<type class="Binding"/>
<theme idref="T33"/>
<theme idref="A9" idref1="T34"/>
<clue><clueExperiment>In electrophoretic mobility shift assays</clueExperiment>, NF kappa B <clueType>binds</clueType> <linkTheme>to</linkTheme> both conserved sites in the HIV-1 transcriptional enhancer and only to the single conserved site in the HIV-2 transcriptional enhancer.</clue>
</event>
<event id="E15">
<type class="Binding"/>
<theme idref="T33"/>
<theme idref="A12" idref1="T36"/>
<clue><clueExperiment>In electrophoretic mobility shift assays</clueExperiment>, NF kappa B <clueType>binds</clueType> to both conserved sites in the HIV-1 transcriptional enhancer and only <linkTheme>to</linkTheme> the single conserved site in the HIV-2 transcriptional enhancer.</clue>
</event>
<sentence id="S9">Instead of <term id="T38" lex="NF_kappa_B" sem="Protein_molecule">NF kappa B</term>, the <term id="T39" lex="activator_protein_3" sem="Protein_molecule">activator protein 3</term> binds to the <term id="A11" sem="DNA_domain_or_region">divergent site</term> in <term id="T40" lex="HIV-2" sem="Virus">HIV-2</term>.</sentence>
<event id="E16">
<type class="Binding"/>
<theme idref="T39"/>
<theme idref="A11" idref1="T40"/>
<clue>Instead of NF kappa B, the activator protein 3 <clueType>binds</clueType> <linkTheme>to</linkTheme> the divergent site in HIV-2.</clue>
</event>
<sentence id="S10">In conclusion, <term id="T41" lex="HIV-1" sem="Virus">HIV-1</term> and <term id="T42" lex="HIV-2" sem="Virus">HIV-2</term> are differentially regulated by <term id="A10" sem="Other"><term id="T43" lex="T_cell_activation" sem="Other">T cell activation</term> signals</term>, and this difference may account for the longer period of <term id="T44" lex="viral_latency" sem="Other">viral latency</term> observed with <term id="T45" lex="HIV-2" sem="Virus">HIV-2</term> than with <term id="T46" lex="HIV-1_infection" sem="Other"><term id="T47" lex="HIV-1" sem="Virus">HIV-1</term> infection</term>.</sentence>
<event id="E17">
<type class="Regulation"/>
<theme idref="T41"/>
<cause idref="A10"/>
<clue>In conclusion, HIV-1 and HIV-2 are differentially <clueType>regulated</clueType> <linkCause>by</linkCause> T cell activation signals, and this difference may account for the longer period of viral latency observed with HIV-2 than with HIV-1 infection.</clue>
</event>
<event id="E18">
<type class="Regulation"/>
<theme idref="T42"/>
<cause idref="A10"/>
<clue>In conclusion, HIV-1 and HIV-2 are differentially <clueType>regulated</clueType> <linkCause>by</linkCause> T cell activation signals, and this difference may account for the longer period of viral latency observed with HIV-2 than with HIV-1 infection.</clue>
</event>
<event KT="Other" id="E19">
<type class="Initiation_of_viral_infection"/>
<theme idref="T45"/>
<clue>In conclusion, HIV-1 and HIV-2 are differentially regulated by T cell activation signals, and this difference may account for the longer period of viral latency observed with HIV-2 than with HIV-1 <clueType>infection</clueType>.</clue>
</event>
<event KT="Other" id="E20">
<type class="Initiation_of_viral_infection"/>
<theme idref="T47"/>
<clue>In conclusion, HIV-1 and HIV-2 are differentially regulated by T cell activation signals, and this difference may account for the longer period of viral latency observed with HIV-2 than with HIV-1 <clueType>infection</clueType>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
